Both in Pharmaceuticals
XBiotech vs Citius Oncology
Over the past year XBIT returned −16.7% and CTOR returned −66.9%; their daily moves had a correlation of 0.11.
XBIT −16.7% CTOR −66.9%Growth of $1, one year, split-adjusted
| Metric | XBIT | CTOR |
|---|---|---|
| Price | $1.99 | $0.5768 |
| Market cap | $60.7M | $61.0M |
| Today | +7.57% | −5.60% |
| 1 month | −8.7% | −45.1% |
| 6 months | −21.0% | −32.9% |
| Year to date | −16.7% | −42.3% |
| 1 year | −22.6% | −66.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 67.1% |
| Net margin | — | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.6× |
| Net cash | $109.5M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | 101.6% |
| Short % of float | 1.8% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).